CRISPR Therapeutics AG (CRSP): 4 insider purchases in the last two years; 3 trades disclosed by members of Congress.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jan 27, 2026 | Patel Naimish Officer | 1,508 | $32.96 | $49.7K | no history |
| Aug 8, 2025 | Treco Douglas A Director | 20,000 | $57.03 | $1.1M | no history |
| Jul 17, 2025 | George Simeon Director | 989,812 | $52.03 | $51.5M | no history |
| Feb 28, 2025 | Greene John Director | 7,000 | $44.85 | $313.9K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.
| Filed | Member | Type | Amount |
|---|---|---|---|
| Oct 5, 2021 | Thomas Suozzi | sale | $50,001 - c |
| Sep 23, 2021 | Thomas Suozzi | purchase | $50,001 - c |
| Feb 19, 2021 | Mrs. Marjorie Taylor Greene | purchase | $1,001 - $15,000 c |